Delayed
Nasdaq
10:13:23 2024-06-03 am EDT
|
5-day change
|
1st Jan Change
|
0.2548
USD
|
+1.51%
|
|
-0.08%
|
-36.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
270.5
|
1,076
|
120.5
|
9.938
|
14.67
|
12.04
|
-
|
-
|
Enterprise Value (EV)
1 |
270.5
|
1,076
|
120.5
|
9.938
|
14.67
|
12.04
|
12.04
|
12.04
|
P/E ratio
|
-10.5
x
|
-42.9
x
|
-2.55
x
|
-0.14
x
|
-0.12
x
|
-0.63
x
|
-1.09
x
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.71
x
|
13
x
|
1.43
x
|
-
|
1.15
x
|
1.02
x
|
0.47
x
|
0.29
x
|
EV / Revenue
|
7.71
x
|
13
x
|
1.43
x
|
-
|
1.15
x
|
1.02
x
|
0.47
x
|
0.29
x
|
EV / EBITDA
|
-14,099,794
x
|
-250,784,434
x
|
-34,870,355
x
|
-
|
-994,787
x
|
-
|
-
|
-
|
EV / FCF
|
-
|
-133,861,924
x
|
-3,934,938
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
2,764
|
2,903
|
3,194
|
4,506
|
36,591
|
47,967
|
-
|
-
|
Reference price
2 |
97.86
|
370.7
|
37.74
|
2.206
|
0.4010
|
0.2510
|
0.2510
|
0.2510
|
Announcement Date
|
3/12/20
|
3/1/21
|
3/8/22
|
3/15/23
|
4/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
35.1
|
82.84
|
84.13
|
-
|
12.74
|
11.8
|
25.66
|
41.22
|
EBITDA
|
-19.18
|
-4.291
|
-3.457
|
-
|
-14.75
|
-
|
-
|
-
|
EBIT
1 |
-20.01
|
-14.92
|
-27.98
|
-
|
-21.13
|
-13.49
|
-4.884
|
3.613
|
Operating Margin
|
-57.03%
|
-18.01%
|
-33.26%
|
-
|
-165.83%
|
-114.33%
|
-19.04%
|
8.77%
|
Earnings before Tax (EBT)
1 |
-25.7
|
-23.36
|
-
|
-
|
-28
|
-26.33
|
-18.89
|
-0.39
|
Net income
1 |
-25.7
|
-24.7
|
-46.1
|
-51.57
|
-36.87
|
-26.33
|
-18.89
|
-0.39
|
Net margin
|
-73.23%
|
-29.81%
|
-54.79%
|
-
|
-289.37%
|
-223.17%
|
-73.62%
|
-0.95%
|
EPS
2 |
-9.360
|
-8.640
|
-14.82
|
-15.60
|
-3.300
|
-0.4000
|
-0.2300
|
-
|
Free Cash Flow
|
-
|
-8.039
|
-30.64
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-9.7%
|
-36.41%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/12/20
|
3/1/21
|
3/8/22
|
3/15/23
|
4/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2023 Q2
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
18.59
|
10.33
|
5.258
|
3.903
|
2.843
|
2.96
|
3.539
|
2.68
|
2.6
|
3
|
3.518
|
EBITDA
|
-1.708
|
-6.456
|
-9.188
|
-8.575
|
-7.7
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-5.468
|
-17.98
|
-13.14
|
-11.91
|
-11.06
|
-
|
-5.213
|
-4.273
|
-3.382
|
-3.101
|
-2.733
|
Operating Margin
|
-29.41%
|
-174.04%
|
-250%
|
-305.15%
|
-389.13%
|
-
|
-147.3%
|
-159.44%
|
-130.08%
|
-103.37%
|
-77.69%
|
Earnings before Tax (EBT)
1 |
-7.883
|
-
|
-14.54
|
-15.04
|
-12.74
|
-
|
-6.396
|
-4.458
|
-6.621
|
-6.54
|
-6.472
|
Net income
1 |
-10.12
|
-22.29
|
-16.88
|
-17.3
|
-15
|
-8.994
|
-15.35
|
-4.458
|
-6.621
|
-6.54
|
-6.472
|
Net margin
|
-54.44%
|
-215.73%
|
-321.11%
|
-443.15%
|
-527.72%
|
-303.85%
|
-433.74%
|
-166.34%
|
-254.65%
|
-218%
|
-183.97%
|
EPS
2 |
-3.240
|
-6.720
|
-4.860
|
-4.980
|
-3.720
|
-1.840
|
-0.2900
|
-0.1100
|
-0.1000
|
-0.1000
|
-0.0900
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/4/21
|
3/8/22
|
5/11/22
|
8/9/22
|
11/9/22
|
8/9/23
|
4/16/24
|
5/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-8.04
|
-30.6
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-44.4%
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-29.3%
|
-19.8%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
84.28
|
232.9
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
1.76
|
4.48
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
2.12%
|
5.32%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/12/20
|
3/1/21
|
3/8/22
|
3/15/23
|
4/16/24
|
-
|
-
|
-
|
Last Close Price
0.251
USD Average target price
4
USD Spread / Average Target +1,493.63% Consensus |
1st Jan change
|
Capi.
|
---|
| -37.41% | 12.04M | | +25.52% | 88.99B | | -24.52% | 74.82B | | +0.49% | 26.63B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +79.20% | 13.21B | | +70.11% | 13.08B | | +40.44% | 12.9B |
Other Healthcare Facilities & Services
|